Acquiring Company
DSM-Firmenich
Acquired Company
N/A
Maastricht
BowmansvilleBiotechnologyHealth CareConstructionBuilding MaintenanceDescription
DSM-Firmenich's Board of Directors has proposed Richard Ridinger as the new Chairman. This transition comes following the completion of the company's merger and is aimed at focusing on executing the group's strategic direction. Leysen will retire after overseeing the company's formation and integration. The leadership change signals a move towards improving margins and driving growth.
Don't miss DSM-Firmenich's next move
Get an email the moment DSM-Firmenich makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired N/A?
N/A was acquired by DSM-Firmenich, based in Maastricht. The deal was reported on August 19, 2026. DSM-Firmenich is a science-driven company focused on nutrition, health and beauty across human and animal markets. It emerged from the 2023 merger of Dutch DSM and Swiss Firmenich. DSM-Firmenich is privately held and operates in Biotechnology.
When did DSM-Firmenich acquire N/A?
DSM-Firmenich's acquisition of N/A was reported on August 19, 2026. DSM-Firmenich's Board of Directors has proposed Richard Ridinger as the new Chairman. This transition comes following the completion of the company's merger and is aimed at focusing on executing the group's strategic direction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does N/A do?
N/A It is privately held, operating in Construction, and is based in Bowmansville.